Replies to post #7072 on Tonix Pharmaceuticals Holding Corp (TNXP)

[daleb2130]

They have no reason to do a RS. If they need money there are plenty of shares to raise money,

On August 31, 2020, the Tonix Pharmaceuticals Holding Corp. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada to increase the number of authorized shares of the Company’s common stock from 150,000,000 to 400,000,000 shares (the “Charter Amendment”).



As previously disclosed, the Charter Amendment was approved by the Company’s shareholders at a special meeting of shareholders held on August 28, 2020. The foregoing description of the Charter Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Charter Amendment, a copy of which is filed as Exhibit 3.01 to this Current Report on Form 8-K and incorporated in this Item 5.03 by reference.

[daleb2130]

And there is this. Nasdaq compliant

On August 4, 2020, Tonix Pharmaceuticals Holding Corp. (the “Company”) issued a press release announcing that on August 3, 2020, the Company received a letter from The NASDAQ Stock Market LLC ("NASDAQ") stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten consecutive business days, the Company’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the NASDAQ Global Market, as set forth in NASDAQ Listing Rule 5450(a)(1), and that the matter is now closed. A copy of the press release that discusses this matter is filed as Exhibit 99.01 to, and incorporated by reference in, this report.

Also on August 4, 2020, the Company posted a presentation which was presented at the American Academy of Neurology’s Sports Concussion Conference held July 31, 2020 and August 1, 2020 (the “Presentation”). Copies of the Presentation and the press release which discusses this matter are filed as Exhibits 99.02 and 99.03, respectively, and are incorporated by reference in, this report.